|
1
|
Kirchhof P, Benussi S, Kotecha D, Ahlsson
A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks
J, et al: 2016 ESC Guidelines for the management of atrial
fibrillation developed in collaboration with EACTS. Europace.
18:1609–1678. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Feinberg WM, Blackshear JL, Laupacis A,
Kronmal R and Hart RG: Prevalence, age distribution, and gender of
patients with atrial fibrillation. Analysis and implications. Arch
Intern Med. 155:469–473. 1995.PubMed/NCBI
|
|
3
|
Go AS, Hylek EM, Phillips KA, Chang Y,
Henault LE, Selby JV and Singer DE: Prevalence of diagnosed atrial
fibrillation in adults: national implications for rhythm management
and stroke prevention: the AnTicoagulation and risk factors in
atrial fibrillation (ATRIA) study. JAMA. 285:2370–2375.
2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zoni-Berisso M, Lercari F, Carazza T and
Domenicucci S: Epidemiology of atrial fibrillation: European
perspective. Clin Epidemiol. 6:213–220. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kuck KH, Brugada J, Fürnkranz A, Metzner
A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, et
al: Cryoballoon or radiofrequency ablation for paroxysmal atrial
fibrillation. N Engl J Med. 374:2235–2245. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lioni L, Letsas KP, Efremidis M, Vlachos
K, Giannopoulos G, Kareliotis V, Deftereos S and Sideris A:
Catheter ablation of atrial fibrillation in the elderly. J Geriatr
Cardiol. 11:291–295. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kawamura I, Aikawa T, Yokoyama Y, Takagi H
and Kuno T: Catheter ablation for atrial fibrillation in elderly
patients: Systematic review and a meta-analysis. Pacing Clin
Electrophysiol. 45:59–71. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ikenouchi T, Nitta J, Nitta G, Kato S,
Iwasaki T, Murata K, Junji M, Hirao T, Kanoh M, Takamiya T, et al:
Propensity-matched comparison of cryoballoon and radiofrequency
ablation for atrial fibrillation in elderly patients. Heart Rhythm.
16:838–845. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xing Y, Xu B, Sheng X, Xu C, Peng F, Sun
Y, Wang S and Guo H: Efficacy and safety of uninterrupted
low-intensity warfarin for cryoballoon ablation of atrial
fibrillation in the elderly: A pilot study. J Clin Pharm Ther.
43:401–407. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group. Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. J Clin Epidemiol.
62:1006–1012. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lo CK, Mertz D and Loeb M:
Newcastle-Ottawa Scale: Comparing reviewers' to authors'
assessments. BMC Med Res Methodol. 14(45)2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tscholl V, Lin T, Lsharaf AK, Bellmann B,
Nagel P, Lenz K, Landmesser U, Roser M and Rillig A: Cryoballoon
ablation in the elderly: One year outcome and safety of the
second-generation 28 mm cryoballoon in patients over 75 years old.
Europace. 20:772–777. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang J, Ren Z, Wang S, Zhang J, Yang H,
Zheng Y, Meng W, Zhao D and Xu Y: Efficacy and safety of
cryoballoon ablation for Chinese patients over 75 years old: A
comparison with a younger cohort. Journal Of Cardiovascular
Electrophysiology. 30:2734–2742. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Heeger CH, Bellmann B, Fink T, Bohnen JE,
Wissner E, Wohlmuth P, Rottner L, Sohns C, Tilz RR, Mathew S, et
al: Efficacy and safety of cryoballoon ablation in the elderly: A
multicenter study. Int J Cardiol. 278:108–113. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Abugattas JP, Iacopino S, Moran D, De
Regibus V, Takarada K, Mugnai G, Ströker E, Coutiño-Moreno HE,
Choudhury R, Storti C, et al: Efficacy and safety of the second
generation cryoballoon ablation for the treatment of paroxysmal
atrial fibrillation in patients over 75 years: A comparison with a
younger cohort. Europace. 19:1798–1803. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Abdin A, Yalin K, Lyan E, Sawan N, Liosis
S, Meyer-Saraei R, Elsner C, Lange SA, Heeger CH, Eitel C, et al:
Safety and efficacy of cryoballoon ablation for the treatment of
atrial fibrillation in elderly patients. Clin Res Cardiol.
108:167–174. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kanda T, Masuda M, Kurata N, Asai M, Iida
O, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Okuno S, et al:
Efficacy and safety of the cryoballoon-based atrial fibrillation
ablation in patients aged ≥80 years. J Cardiovasc Electrophysiol.
30:2242–2247. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Haïssaguerre M, Jaïs P, Shah DC, Takahashi
A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P and
Clémenty J: Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary veins. N Engl J Med.
339:659–666. 1998.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Calkins H, Kuck KH, Cappato R, Brugada J,
Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J,
et al: 2012 HRS/EHRA/ECAS expert consensus statement on catheter
and surgical ablation of atrial fibrillation: Recommendations for
patient selection, procedural techniques, patient management and
follow-up, definitions, endpoints, and research trial design: A
report of the heart rhythm society (HRS) task force on catheter and
surgical ablation of atrial fibrillation. Developed in partnership
with the European heart rhythm association (EHRA), a registered
branch of the European society of cardiology (ESC) and the European
cardiac arrhythmia society (ECAS); and in collaboration with the
American college of cardiology (ACC), American heart association
(AHA), the Asia pacific heart rhythm society (APHRS), and the
society of thoracic surgeons (STS). Endorsed by the governing
bodies of the American college of cardiology foundation, the
American heart association, the European cardiac arrhythmia
society, the European heart rhythm association, the society of
thoracic surgeons, the Asia pacific heart rhythm society, and the
heart rhythm society. Heart Rhythm. 9:632–696.e21. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jaïs P, Cauchemez B, Macle L, Daoud E,
Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P,
et al: Catheter ablation versus antiarrhythmic drugs for atrial
fibrillation: The A4 study. Circulation. 118:2498–2505.
2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wilber DJ, Pappone C, Neuzil P, De Paola
A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B,
et al: Comparison of antiarrhythmic drug therapy and radiofrequency
catheter ablation in patients with paroxysmal atrial fibrillation:
A randomized controlled trial. JAMA. 303:333–340. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wazni OM, Marrouche NF, Martin DO, Verma
A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther
J, et al: Radiofrequency ablation vs antiarrhythmic drugs as
first-line treatment of symptomatic atrial fibrillation: A
randomized trial. JAMA. 293:2634–2640. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hiasa KI, Kaku H, Inoue H, Yamashita T,
Akao M, Atarashi H, Koretsune Y, Okumura K, Shimizu W, Ikeda T, et
al: Age-related differences in the clinical characteristics and
treatment of elderly patients with atrial fibrillation in
Japan-insight from the ANAFIE (All Nippon AF In Elderly) registry.
Circ J. 84:388–396. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shao XH, Yang YM, Zhu J, Zhang H, Liu Y,
Gao X, Yu LT, Liu LS, Zhao L, Yu PF, et al: Comparison of the
clinical features and outcomes in two age-groups of elderly
patients with atrial fibrillation. Clin Interv Aging. 9:1335–1342.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zakeri R, Chamberlain AM, Roger VL and
Redfield MM: Temporal relationship and prognostic significance of
atrial fibrillation in heart failure patients with preserved
ejection fraction: A community-based study. Circulation.
128:1085–1093. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Packer DL, Kowal RC, Wheelan KR, Irwin JM,
Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, et
al: Cryoballoon ablation of pulmonary veins for paroxysmal atrial
fibrillation: First results of the North American arctic front
(STOP AF) pivotal trial. J Am Coll Cardiol. 61:1713–1723.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Morillo CA, Verma A, Connolly SJ, Kuck KH,
Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS and Natale A:
RAAFT-2 Investigators. Radiofrequency ablation vs antiarrhythmic
drugs as first-line treatment of paroxysmal atrial fibrillation
(RAAFT-2): A randomized trial. JAMA. 311:692–700. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Corrado A, Patel D, Riedlbauchova L, Fahmy
TS, Themistoclakis S, Bonso A, Rossillo A, Hao S, Schweikert RA,
Cummings JE, et al: Efficacy, safety, and outcome of atrial
fibrillation ablation in septuagenarians. J Cardiovasc
Electrophysiol. 19:807–811. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zado E, Callans DJ, Riley M, Hutchinson M,
Garcia F, Bala R, Lin D, Cooper J, Verdino R, Russo AM, et al:
Long-term clinical efficacy and risk of catheter ablation for
atrial fibrillation in the elderly. J Cardiovasc Electrophysiol.
19:621–626. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Haegeli LM, Duru F, Lockwood EE, Lüscher
TF, Sterns LD, Novak PG and Leather RA: Ablation of atrial
fibrillation after the retirement age: Considerations on safety and
outcome. J Interv Card Electrophysiol. 28:193–197. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Baman TS, Jongnarangsin K, Chugh A,
Suwanagool A, Guiot A, Madenci A, Walsh S, Ilg KJ, Gupta SK,
Latchamsetty R, et al: Prevalence and predictors of complications
of radiofrequency catheter ablation for atrial fibrillation. J
Cardiovasc Electrophysiol. 22:626–631. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Deshmukh A, Patel NJ, Pant S, Shah N,
Chothani A, Mehta K, Grover P, Singh V, Vallurupalli S, Savani GT,
et al: In-hospital complications associated with catheter ablation
of atrial fibrillation in the United States between 2000 and 2010:
Analysis of 93 801 procedures. Circulation. 128:2104–2112.
2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cappato R, Calkins H, Chen SA, Davies W,
Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, et al:
Updated worldwide survey on the methods, efficacy, and safety of
catheter ablation for human atrial fibrillation. Circ Arrhythm
Electrophysiol. 3:32–38. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Thomas D, Katus HA and Voss F:
Asymptomatic pulmonary vein stenosis after cryoballoon catheter
ablation of paroxysmal atrial fibrillation. J Electrocardiol.
44:473–476. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rottner L, Fink T, Heeger CH, Schlüter M,
Goldmann B, Lemes C, Maurer T, Reißmann B, Rexha E, Riedl J, et al:
Is less more? Impact of different ablation protocols on
periprocedural complications in second-generation cryoballoon based
pulmonary vein isolation. Europace. 20:1459–1467. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tokutake K, Tokuda M, Ogawa T, Matsuo S,
Yoshimura M and Yamane T: Pulmonary vein stenosis after
second-generation cryoballoon ablation for atrial fibrillation.
HeartRhythm Case Rep. 3:36–39. 2017.PubMed/NCBI View Article : Google Scholar
|
